BB, ARNI, MRA, vasodilator, or diuretic use was not associated with any significant effects on all‐cause mortality, although there was a trend for ARNI to reduce the risk of death (HR 0.37 [95% CI: 0.09–1.48]), but this did not reach statistical significance ( P = 0.16) ( Figure 2 ).
← all excerpts
Retrospective analysis of SGLT2 inhibitors in heart failure with preserved ejection fraction.
1
0.1600
0.1600